Search Results - "Mousa, S A"

Refine Results
  1. 1

    Emerging therapies for Parkinson's disease: From bench to bedside by TARAZI, F. I, SAHLI, Z. T, WOLNY, M, MOUSA, S. A

    Published in Pharmacology & therapeutics (Oxford) (01-11-2014)
    “…The prevalence of Parkinson's disease (PD) increases with age and is projected to increase in parallel to the rising average age of the population. The disease…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid by Yalcin, M, Dyskin, E, Lansing, L, Bharali, D. J, Mousa, S. S, Bridoux, A, Hercbergs, A. H, Lin, H. Y, Davis, F. B, Glinsky, G. V, Glinskii, A, Ma, J, Davis, P. J, Mousa, S. A

    “…Context: Tetraiodothyroacetic acid (tetrac) blocks angiogenic and tumor cell proliferation actions of thyroid hormone initiated at the cell surface hormone…”
    Get full text
    Journal Article
  5. 5

    Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease by Qari, M H, Dier, U, Mousa, S A

    Published in Clinical and applied thrombosis/hemostasis (01-04-2012)
    “…Acute painful crisis is a common sequela that can cause significant morbidity and negatively impact the quality of life of patients with sickle cell disease…”
    Get more information
    Journal Article
  6. 6

    Optimal life-insurance selection and purchase within a market of several life-insurance providers by Mousa, A.S., Pinheiro, D., Pinto, A.A.

    Published in Insurance, mathematics & economics (01-03-2016)
    “…We consider the problem faced by a wage-earner with an uncertain lifetime having to reach decisions concerning consumption and life-insurance purchase, while…”
    Get full text
    Journal Article
  7. 7

    Tetraidothyroacetic Acid (Tetrac) and Tetrac Nanoparticles Inhibit Growth of Human Renal Cell Carcinoma Xenografts by YALCIN, M, BHARALI, D. J, LANSING, L, DYSKIN, E, MOUSA, S. S, HERCBERGS, A, DAVIS, F. B, DAVIS, P. J, MOUSA, S. A

    Published in Anticancer research (01-10-2009)
    “…Renal cell carcinoma is the most lethal of the common urologic malignancies, with no available effective therapeutics. Tetrac (tetraiodothyroacetic acid) is a…”
    Get full text
    Journal Article
  8. 8

    Asperger's syndrome: diagnosis, comorbidity and therapy by Tarazi, F I, Sahli, Z T, Pleskow, J, Mousa, S A

    Published in Expert review of neurotherapeutics (01-03-2015)
    “…Asperger's syndrome (AS), a behavioral disorder that is related to autism, is associated with abnormal social functioning and repetitive behaviors but not with…”
    Get more information
    Journal Article
  9. 9

    Antagonistic potential of some phosphate solubilizing fungi against some phyto-pathogenic fungi by Nasr, Siada H., Mousa, A. S. M., Yasser, M. M., Marzouk, M. A.

    “…Background Little phosphorus availability in soil is one of the major forces for crop production. Phosphate solubilizing fungi enhance available phosphorus…”
    Get full text
    Journal Article
  10. 10

    Greasing the wheels of managing overweight and obesity with omega-3 fatty acids by Golub, N, Geba, D, Mousa, S.A, Williams, G, Block, R.C

    Published in Medical hypotheses (01-12-2011)
    “…Abstract The epidemic of overweight and obesity around the world and in the US is a major public health challenge, with 1.5 billion overweight and obese adults…”
    Get full text
    Journal Article
  11. 11

    Antimetastatic effect of tinzaparin, a low‐molecular‐weight heparin by Amirkhosravi, A., Mousa, S. A., Amaya, M., Francis, J. L.

    Published in Journal of thrombosis and haemostasis (01-09-2003)
    “…The importance of coagulation activation in cancer patients is suggested by the clinical finding of hypercoagulability, experimental enhancement of metastasis…”
    Get full text
    Journal Article
  12. 12

    Preliminary evaluation of nonpenetrating deep sclerectomy with autologous scleral implant in open-angle glaucoma by MOUSA, A. S. G

    Published in Eye (London) (01-09-2007)
    “…The aim of this study is to evaluate the short-term result of the use of an autologous scleral implant during the nonpenetrating deep sclerectomy operation…”
    Get full text
    Journal Article
  13. 13

    Opioid peptide-expressing leukocytes: Identification, recruitment, and simultaneously increasing inhibition of Inflammatory pain by RITTNER, Heike L, BRACK, Alexander, MACHELSKA, Halina, MOUS, Shaaban A, BAUER, Monika, SCHÄFER, Michael, STEIN, Christoph

    Published in Anesthesiology (Philadelphia) (01-08-2001)
    “…Inflammatory pain can be effectively controlled by an interaction of opioid receptors on peripheral sensory nerve terminals with opioid peptides released from…”
    Get full text
    Journal Article
  14. 14

    Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model by Mousa, S A, Davis, F B, Mohamed, S, Davis, P J, Feng, X

    Published in International angiology (01-12-2006)
    “…Our laboratory has recently demonstrated the pro-angiogenesis effects of thyroid hormone in the chick chorioallantoic membrane model. Generation of new blood…”
    Get more information
    Journal Article
  15. 15

    Optimal social welfare policy within financial and life insurance markets by Hoshiea, M., Mousa, A. S., Pinto, A. A.

    Published in Optimization (02-09-2023)
    “…We consider a continuous lifetime model for investor whose lifetime is a random variable. We assume the investor has an access to the social welfare system,…”
    Get full text
    Journal Article
  16. 16

    Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model by Khan, Naghma, Bharali, Dhruba J, Adhami, Vaqar M, Siddiqui, Imtiaz A, Cui, Huadong, Shabana, Sameh M, Mousa, Shaker A, Mukhtar, Hasan

    Published in Carcinogenesis (New York) (01-02-2014)
    “…In preclinical animal models, several phytochemicals have shown excellent potential to be used as effective agents in preventing and treating many cancers…”
    Get full text
    Journal Article
  17. 17

    Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia by Likar, R., Mousa, S.A., Philippitsch, G., Steinkellner, H., Koppert, W., Stein, C., Schäfer, M.

    Published in British journal of anaesthesia : BJA (01-09-2004)
    “…Both locally expressed β-endorphin (END) and low doses of morphine relieve pain within inflamed knee joints. Here we examined whether enhanced inflammation and…”
    Get full text
    Journal Article
  18. 18

    Antinociception by neutrophil-derived opioid peptides in noninflamed tissue—Role of hypertonicity and the perineurium by Rittner, H.L, Hackel, D, Yamdeu, R.-S, Mousa, S.A, Stein, C, Schäfer, M, Brack, A

    Published in Brain, behavior, and immunity (01-05-2009)
    “…Abstract Inflammatory pain can be controlled by intraplantar opioid injection or by secretion of endogenous opioid peptides from leukocytes in inflamed rat…”
    Get full text
    Journal Article
  19. 19

    Optimal consumption, investment and life-insurance purchase under a stochastically fluctuating economy by Mousa, A.S., Pinheiro, D., Pinheiro, S., Pinto, A.A.

    Published in Optimization (01-02-2024)
    “…We study the optimal consumption, investment and life-insurance purchase and selection strategies for a wage-earner with an uncertain lifetime with access to a…”
    Get full text
    Journal Article
  20. 20

    Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis by COLMAN, R. W, JAMESON, B. A, YINGZHANG LIN, JOHNSON, D, MOUSA, S. A

    Published in Blood (15-01-2000)
    “…We have demonstrated that high molecular weight kininogen (HK) binds specifically on endothelial cells to domain 2/3 of the urokinase receptor (uPAR)…”
    Get full text
    Journal Article